[Malignant hyperthermia caused by neuroleptics].
Escolano Villén
F
F
Aguilar Sánchez
J L
JL
Castrillo Ferrando
A
A
Beser Gascón
P
P
Sabaté Pes
A
A
Campos Suárez
J M
JM
Villar Landeira
J M
JM
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004338:Drug Combinations; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000188:drug therapy / Q000209:etiology*; D008728:Methotrimeprazine / Q000009:adverse effects* / Q000627:therapeutic use; D010276:Parasympatholytics / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D004338:Drug Combinations; D010276:Parasympatholytics; D003907:Dexamethasone; D004155:Diphenhydramine; D008728:Methotrimeprazine; D006220:Haloperidol
Hiperpirexia maligna por neurolépticos.